Free Trial
NASDAQ:ARDM

Aradigm (ARDM) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.15
$0.38
52-Week Range
N/A
Volume
N/A
Average Volume
97,091 shs
Market Capitalization
$761,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ARDM stock logo

About Aradigm Stock (NASDAQ:ARDM)

Aradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. Its lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin, including Linhaliq and Lipoquin that are delivered by inhalation for the management of infections associated with severe respiratory diseases, including non-cystic fibrosis bronchiectasis, cystic fibrosis, and non-tuberculosis mycobacterium. The company is also developing inhaled ciprofloxacin formulations for treatment of patients with cystic fibrosis, and has tested for the prevention and treatment of inhaled bioterrorism infections, such as Coxiella burnetii or Q fever, inhalation anthrax, tularemia, melioidosis and pneumonic plague. Aradigm Corporation has collaboration agreements with Grifols, S.A. The company was founded in 1991 and is headquartered in Hayward, California.

ARDM Stock News Headlines

First International Bank of Israel Ltd (FIBI)
Altshuler Shaham Financial LTD (ALTF)
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
Aerodrome Group Ltd (ARDM)
Aerodrome Group Ltd (ARDM.TA)
How and Why Google Glass Failed
See More Headlines
Receive ARDM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aradigm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2018
Today
7/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:ARDM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-10,700,000.00
Net Margins
-374.80%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$14.47 million
Book Value
($0.83) per share

Miscellaneous

Free Float
N/A
Market Cap
$761,000.00
Optionable
Optionable
Beta
1.57
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Dr. John M. Siebert (Age 79)
    Exec. Chairman, Interim Principal Exec. Officer & Acting Principal Financial Officer
  • Dr. Juergen Froehlich M.D. (Age 62)
    MBA, FCPh, Chief Medical Officer
  • Dr. Igor Gonda (Age 71)
    Consultant
  • Ms. Nancy E. Pecota (Age 59)
    Consultant
  • Lisa Thomas
    Corp. Controller

ARDM Stock Analysis - Frequently Asked Questions

How were Aradigm's earnings last quarter?

Aradigm Co. (NASDAQ:ARDM) released its quarterly earnings results on Thursday, November, 15th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.03. The firm earned $0.28 million during the quarter.

What other stocks do shareholders of Aradigm own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aradigm investors own include Amarin (AMRN), CRISPR Therapeutics (CRSP), Vaxart (VXRT), Nabriva Therapeutics (NBRV), Novavax (NVAX), VBI Vaccines (VBIV) and Aduro Biotech (ADRO).

This page (NASDAQ:ARDM) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners